WHO ICTRP trial
TALTEC: A phase II study measuring MRD negativity after bispecific T-cell…
CTIS2023-508212-38-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-508212-38-00 |
|---|---|
| Public title | TALTEC: A phase II study measuring MRD negativity after bispecific T-cell redirectors TALquetamab and TEClistamab consolidation as part of first line treatment in transplant eligible multiple myeloma patients |
| Scientific title | TALTEC: A phase II study measuring MRD negativity after bispecific T-cell redirectors TALquetamab and TEClistamab consolidation as part of first line treatment in transplant eligible multiple myeloma patients - TALTEC JNJ-54767414 |
| Primary sponsor | North Estonia Medical Centre Foundation |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Denmark;Norway;Estonia |
| Conditions | Multiple Myeloma;Therapeutic area: Diseases [C] - Neoplasms [C04];Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15] |
| Interventions | Product Name: JNJ-64407564, Product Code:PRD10381753, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: teclistamab, Product Code:PRD9936207, Pharmaceutical Form: SOLUTION FOR INJECTION, Other… |
| Registration date | Nov 20, 2023 |
| Target size | 50 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: